PET imaging for prediction of response to therapy and outcome in oesophageal carcinoma

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 9, 2011, Pages 1591-1594

  Chua, Sue ^a   Dickson, John ^b   Groves, Ashley M ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; PROTEIN TYROSINE KINASE INHIBITOR;

CANCER ADJUVANT THERAPY; CANCER SURVIVAL; ESOPHAGUS CARCINOMA; HUMAN; POSITRON EMISSION TOMOGRAPHY; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ESOPHAGEAL NEOPLASMS; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY;

EID: 80455164711     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1858-1     Document Type: Review

References (29)

1. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003;349:2241-52. (Pubitemid 37485141)
2. Ott K, Weber WA, Lordick F, Becker K, Busch R, Herrmann K, et al. Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction. J Clin Oncol 2006;24(29):4692-8. (Pubitemid 46646244)
3. Kwee RM. Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of 18F FDG PET: A systematic review. Radiology 2010;254(3):707-17.
4. Omloo JM, van Heijl M, Hoekstra OS, van Berge Henegouwen MI, van Lanschot JJ, Sloof GW. FDG-PET parameters as prognostic factor in esophageal cancer patients: A review. Ann Surg Oncol 2011 May 3. [Epub ahead of print]
5. Hautzel H, Müller-Gärtner HW. Early changes in fluorine-18-FDG uptake during radiotherapy. J Nucl Med 1997;38:1384-6. (Pubitemid 27386195)
6. Hatt M, Visvikis D, Pradier O, Cheze-le-Rest C. Baseline (18) F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancer. Eur J Nucl Med Mol Imaging 2011. doi:10.1007/s00259-011-1834-9
7. Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 2009;50 Suppl 1:122S-50.
8. Hatt M, Cheze Le Rest C, Albarghach N, Pradier O, Visvikis D. PET functional volume delineation: A robustness and repeatability study. Eur J Nucl Med Mol Imaging 2011;38(4):663-72.
9. Grégoire V, Haustermans K, Geets X, Roels S, Lonneux M. PET-based treatment planning in radiotherapy: A new standard? J Nucl Med 2007;48 Suppl 1:68S-77. (Pubitemid 47604944)
10. Nestle U, Kremp S, Schaefer-Schuler A, Sebastian-Welsch C, Hellwig D, Rübe C, et al. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer. J Nucl Med 2005;46:1342-8. (Pubitemid 43733485)
11. Biehl KJ, Kong FM, Dehdashti F, Jin JY, Mutic S, El Naga I, et al. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate? J Nucl Med 2006;47:1808-12. (Pubitemid 47545003)
12. Hatt M, Visvikis D, Le Rest CC. Autocontouring versus manual contouring. J Nucl Med 2011;52(4):658.
13. Zaidi H, El Naqa I. PET-guided delineation of radiation therapy treatment volumes: A survey of image segmentation techniques. Eur J Nucl Med Mol Imaging 2010;37(11):2165-87.
14. Hatt M, Cheze-Le Rest C, Aboagye EO, Kenny LM, Rosso L, Turkheimer FE, et al. Reproducibility of 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET tumor volume measurements. J Nucl Med 2010;51(9):1368-76.
15. Geets X, Lee JA, Bol A, Lonneux M, Grégoire V. A gradientbased method for segmenting FDG-PET images: methodology and validation. Eur J Nucl Med Mol Imaging 2007;34:1427-38. (Pubitemid 47312577)
16. Pham DL, Prince JL. An adaptive fuzzy C-means algorithm for image segmentation in the presence of intensity inhomogeneities. Pattern Recognit Lett 1999;20:57-68. (Pubitemid 29430718)
17. Hatt M, Cheze le Rest C, Turzo A, Roux C, Visvikis D. A fuzzy locally adaptive Bayesian segmentation approach for volume determination in PET. IEEE Trans Med Imaging 2009;28(6):881-93.
18. Hyun SH, Choi JY, Shim YM, Kim K, Lee SJ, Cho YS, et al. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma. Ann Surg Oncol 2010;17(1):115-22. Epub 2009 Oct. 14.
19. Choi JY, Jang HJ, Shim YM, Kim K, Lee KS, Lee KH, et al. 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications. J Nucl Med 2004;45(11):1843-50. (Pubitemid 47618441)
20. Yendamuri S, Swisher SG, Correa AM, Hofstetter W, Ajani JA, Francis A, et al. Esophageal tumor length is independently associated with long-term survival. Cancer 2009;115(3):508-16.
21. Mamede M, El Fakhri G, Abreu-e-Lima P, Gandler W, Nosé V, Gerbaudo VH. Pre-operative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmation. Ann Nucl Med 2007;21(10):553-62. Epub 2007 Dec. 25. (Pubitemid 350293594)
22. Wanet M, Lee JA, Weynand B, De Bast M, Poncelet A, Lacroix V, et al. Gradient-based delineation of the primary GTVon FDG-PET in non-small cell lung cancer: A comparison with threshold-based approaches, CT and surgical specimens. Radiother Oncol 2011;98:117-25.
23. Kadrmas DJ, Casey ME, Conti M, Jakoby BW, Lois C, Townsend DW. Impact of time-of-flight on PET tumor detection. J Nucl Med 2009;50:1315-23.
24. Wu K, Ung YC, Hwang D, Tsao MS, Darling G, Maziak DE, et al. Autocontouring and manual contouring: which is the better method for target delineation using 18F-FDG PET/CT in nonsmall cell lung cancer? J Nucl Med 2010;51:1517-23.
25. Hatt M, Visvikis D. Defining radiotherapy target volumes using 18F-fluoro-deoxy-glucose positron emission tomography: still a Pandora's box?: in regard to Devic et al. (Int J Radiat Oncol Biol Phys 2010). Int J Radiat Oncol Biol Phys 2010;78(5):1605.
26. Tixier F, Le Rest CC, Hatt M, Albarghach N, Pradier O, Metges JP, et al. Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer. J Nucl Med 2011;52(3):369-78.
27. El Naqa I, Grigsby PW, Apte A, Kidd E, Donnelly E, Khullar D, et al. Exploring feature-based approaches in PET images for predicting cancer treatment outcomes. Pattern Recognit 2009;42:1162-71.
28. Eary JF, O'Sullivan F, O'Sullivan J, Conrad EU. Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome. J Nucl Med 2008;49:1973-9.
29. Lee HY, Hyun SH, Lee KS, Kim BT, Kim J, Shim YM, et al. Volume-based parameter of 18) F-FDG PET/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications. Ann Surg Oncol 2010;17(10):2787-94.